CCND3抗体,Mouse Monoclonal CCND3 Antibody
  • CCND3抗体,Mouse Monoclonal CCND3 Antibody
  • CCND3抗体,Mouse Monoclonal CCND3 Antibody
  • CCND3抗体,Mouse Monoclonal CCND3 Antibody

CCND3抗体

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 湖北
更新日期 2025-05-09
QQ交谈 微信洽谈

产品详情

中文名称:CCND3抗体英文名称:Mouse Monoclonal CCND3 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 385 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Mouse
偶联物: 靶点: CCND3
2025-05-09 CCND3抗体 Mouse Monoclonal CCND3 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 385 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/10000 Human,Mouse,Rat
   

产品详情

AliasesCCND3
Entrez GeneID896
clone6H4
WB Predicted band size32kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse
ImmunogenPurified recombinant fragment of human CCND3 expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

  •  

     

       Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);    


  •  

     

       Western blot analysis using CCND3 mouse mAb against NIH/3T3 (1) and Jurkat (2) cell lysate.    


           

参考文献

以下是关于CCND3抗体的3篇参考文献的简要信息:

1. **文献名称**:*Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) translocation in B-cell malignancies*

**作者**:Sonnenschein H, et al.

**摘要**:该研究揭示了在B细胞淋巴瘤中,染色体易位t(6;14)导致CCND3基因的异常表达,并通过特异性抗体检测发现CCND3蛋白过表达与疾病进展相关,提示其作为潜在治疗靶点。

2. **文献名称**:*CCND3 overexpression enhances chemoresistance in colorectal cancer via β-catenin stabilization*

**作者**:Li Y, et al.

**摘要**:研究利用CCND3抗体分析结直肠癌组织,发现CCND3通过稳定β-catenin信号通路促进肿瘤细胞化疗耐药性,高表达患者预后较差,为靶向干预提供依据。

3. **文献名称**:*Cyclin D3 deficiency inhibits T-cell proliferation and leads to developmental defects in mice*

**作者**:Cooper CL, et al.

**摘要**:通过CCND3抗体在敲除小鼠模型中的研究,发现CCND3缺失导致T细胞增殖受阻和免疫发育异常,证实其在细胞周期调控中的关键作用。

以上文献均围绕CCND3抗体的应用展开,涵盖肿瘤机制、耐药性及免疫调控等领域。

       

背景信息

CCND3 (Cyclin D3) is a member of the D-type cyclin family, which includes CCND1 and CCND2. These proteins play critical roles in regulating the cell cycle progression from the G1 to S phase by forming complexes with cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6. The activated kinase complexes phosphorylate retinoblastoma (Rb) proteins, leading to the release of E2F transcription factors and subsequent initiation of DNA synthesis. CCND3 is encoded by the *CCND3* gene located on chromosome 6q21 and is expressed in various tissues, with higher levels observed in lymphoid cells and certain epithelial tissues.

Antibodies targeting CCND3 are essential tools for studying its expression, localization, and function in both physiological and pathological contexts. These antibodies are widely used in techniques such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry to detect CCND3 protein levels in cell lines, tissue samples, or experimental models. Specificity and validation (e.g., knockout cell lines or siRNA-mediated knockdown) are critical to ensure accurate detection, as cross-reactivity with other D-type cyclins can occur.

Dysregulation of CCND3 has been implicated in cancer. While CCND1 is more commonly associated with malignancies (e.g., mantle cell lymphoma via t(11;14) translocation), CCND3 overexpression or genetic alterations are linked to hematopoietic malignancies, including T-cell acute lymphoblastic leukemia (T-ALL) and multiple myeloma. Conversely, reduced CCND3 expression has been observed in some solid tumors. Research using CCND3 antibodies continues to explore its dual role as an oncogene or tumor suppressor, depending on cellular context, and its potential as a therapeutic target.

       
关键字: CCND3抗体;CCND3;CCND3 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。
成立日期 2024-06-24 (2年) 注册资本 50万(元)
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 中间体,化学试剂 经营模式 贸易,工厂,试剂,定制,服务
  • 湖北瑞和宁生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:50万(元)
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:中间体。试剂
  • 公司地址:江汉区
询盘

店内推荐

CCND3抗体相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP4年
武汉佰乐博生物技术有限公司
2026-01-15
¥1600.00
VIP10年
北京索莱宝科技有限公司
2026-01-15
¥2580
VIP7年
上海泽叶生物科技有限公司
2026-01-15
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.